Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors

被引:164
作者
Alexandre, Francois-Rene [1 ]
Amador, Agnes [1 ]
Bot, Stephanie [1 ]
Caillet, Catherine [1 ]
Convard, Thierry [1 ]
Jakubik, Jocelyn [3 ]
Musiu, Chiara [2 ]
Poddesu, Barbara [2 ]
Vargiu, Luana [2 ]
Liuzzi, Michel [2 ]
Roland, Arlene [1 ]
Seifer, Maria [3 ]
Standring, David [3 ]
Storer, Richard [1 ]
Dousson, Cyril B. [1 ]
机构
[1] Labs Idenix, Dept Chim Med, F-34189 Montpellier 4, France
[2] Univ Cagliari, Cooperat Lab Idenix, Zona Ind Macchiareddu UTA, Idenix Pharmaceut, I-09010 Cagliari, Italy
[3] Idenix Pharmaceut, Cambridge, MA 02139 USA
关键词
ANALOGS; DESIGN; POTENT;
D O I
10.1021/jm101142k
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A novel series of 3-aryl-phospho-indole (API) non-nucleoside reverse transcriptase inhibitors of HIV-1 was developed Chemical variation in the phosphorus linker led to the discovery of 3-phenyl-methyl-phosphinate-2-carboxamide 14, which possessed excellent potency against wild-type HIV-1 as well as viruses bearing K103N and Y181C single mutants in the reverse transcriptase gene Chiral separation of the enantiomers showed that only R enantiomer retained the activity The pharmacokinetic, solubility, and metabolic properties of 14 were assessed
引用
收藏
页码:392 / 395
页数:4
相关论文
共 20 条
  • [1] PREPARATION AND REACTIONS OF 1-(TERT-BUTYLDIMETHYLSILYL)-3-LITHIOINDOLE, REGIOSELECTIVE SYNTHESIS OF 3-SUBSTITUTED INDOLES
    AMAT, M
    HADIDA, S
    SATHYANARAYANA, S
    BOSCH, J
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1994, 59 (01) : 10 - 11
  • [2] [Anonymous], 2006, WO PCT Int. Appl., Patent No. 054182
  • [3] Non-nudeoside reverse transcriptase inhibitors - an overview
    Bell, C
    Matthews, GV
    Nelson, MR
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2003, 14 (02) : 71 - 77
  • [4] Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants
    Das, K
    Clark, AD
    Lewi, PJ
    Heeres, J
    de Jonge, MR
    Koymans, LMH
    Vinkers, HM
    Daeyaert, F
    Ludovici, DW
    Kukla, MJ
    De Corte, B
    Kavash, RW
    Ho, CY
    Ye, H
    Lichtenstein, MA
    Andries, K
    Pauwels, R
    de Béthune, MP
    Boyer, PL
    Clark, P
    Hughes, SH
    Janssen, PAJ
    Arnold, E
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (10) : 2550 - 2560
  • [5] From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1-jk](1,4)benzodiazepin-2(1H)-one (TIBO) to etravirine (TMC125):: Fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase
    De Corte, BL
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (06) : 1689 - 1696
  • [6] SYNTHESIS AND NMR SPECTROSCOPIC INVESTIGATION OF PHENYLPHOSPHORYL DERIVATIVES
    DUDDECK, H
    LECHT, R
    [J]. PHOSPHORUS SULFUR AND SILICON AND THE RELATED ELEMENTS, 1987, 29 (2-4) : 169 - 178
  • [8] Synthesis and antiviral evaluation of thieno[3,4-d] pyrimidine C-nucleoside analogues of 2′,3′-dideoxy- and 2′,3′-dideoxy-2′,3′-didehydro-adenosine and -inosine
    Hamann, Marie
    Pierra, Claire
    Sommadossi, Jean-Pierre
    Musiu, Chiara
    Vargiu, Luana
    Liuzzi, Michel
    Storer, Richard
    Gosselin, Gilles
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (06) : 2321 - 2326
  • [9] Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
    Hopkins, AL
    Ren, JS
    Milton, J
    Hazen, RJ
    Chan, JH
    Stuart, DI
    Stammers, DK
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (24) : 5912 - 5922
  • [10] Novel HIV-1 reverse transcriptase inhibitors
    Jochmans, Dirk
    [J]. VIRUS RESEARCH, 2008, 134 (1-2) : 171 - 185